Explore

Pfizer Raises 2026 Annual Revenue Forecast, CEO Albert Bourla to Speak at London Healthcare Conference

Pfizer Raises 2026 Annual Revenue Forecast, CEO Albert Bourla to Speak at London Healthcare Conference

Pfizer Raises 2026 Annual Revenue Forecast, CEO Albert Bourla to Speak at London Healthcare Conference

Moderna to Join MSCI World Index Amidst New mNEXSPIKE Vaccine Data Publication

Moderna to Join MSCI World Index Amidst New mNEXSPIKE Vaccine Data Publication

Moderna to Join MSCI World Index Amidst New mNEXSPIKE Vaccine Data Publication

Pfizer Secures $1.5 Billion from Blackstone for Obesity Drug Development, Stock Target Raised

Pfizer Secures $1.5 Billion from Blackstone for Obesity Drug Development, Stock Target Raised

Pfizer Secures $1.5 Billion from Blackstone for Obesity Drug Development, Stock Target Raised

Kraft Heinz Dividend Stability Amidst Strategic Reinvestment and Falling Free Cash Flow

Kraft Heinz Dividend Stability Amidst Strategic Reinvestment and Falling Free Cash Flow

Kraft Heinz Dividend Stability Amidst Strategic Reinvestment and Falling Free Cash Flow

Meta Platforms Stock Closes at $641.69 Amidst Market Fluctuations and AI Investment Scrutiny

Meta Platforms Stock Closes at $641.69 Amidst Market Fluctuations and AI Investment Scrutiny

Meta Platforms Stock Closes at $641.69 Amidst Market Fluctuations and AI Investment Scrutiny

C.H. Robinson Stock Receives 'Strong Buy' Rating Amidst Expected EPS Growth

C.H. Robinson Stock Receives 'Strong Buy' Rating Amidst Expected EPS Growth

C.H. Robinson Stock Receives 'Strong Buy' Rating Amidst Expected EPS Growth

CMS Finalizes Guidelines for Medicare Drug Price Negotiation Program, Permanent by 2029

CMS Finalizes Guidelines for Medicare Drug Price Negotiation Program, Permanent by 2029

The Centers for Medicare & Medicaid Services (CMS) has finalized the guidelines for the Medicare Drug Price Negotiation Program, which is set to become a permanent fixture starting in 2029. This program, established by the Inflation Reduction Act of 2022, empowers CMS to directly negotiate drug prices with manufacturers for high-cost medications covered under Medicare's Part B and Part D programs. Under the finalized rule, CMS will identify and publish a list of up to 20 selected drugs for negotiation or renegotiation. The agency will then enter into agreements with participating manufacturers to establish maximum fair prices for these drugs and will publish these agreed-upon prices. The program also includes provisions for imposing civil monetary penalties when necessary. This initiative aims to reduce the cost of prescription drugs for Medicare beneficiaries, though it will not apply to all drugs, take immediate effect, or eliminate all differences between Medicare plans. The implementation of this progr...

Cincinnati Financial Corporation Declares Regular Quarterly Cash Dividend of 94 Cents Per Share

Cincinnati Financial Corporation Declares Regular Quarterly Cash Dividend of 94 Cents Per Share

Cincinnati Financial Corporation Declares Regular Quarterly Cash Dividend of 94 Cents Per Share

Norfolk Southern Stock Valuation Questioned Amidst Strong Returns and Regulatory Scrutiny

Norfolk Southern Stock Valuation Questioned Amidst Strong Returns and Regulatory Scrutiny

Norfolk Southern Stock Valuation Questioned Amidst Strong Returns and Regulatory Scrutiny

Public Storage Declares Quarterly Dividends Amidst Raised Full-Year Guidance

Public Storage Declares Quarterly Dividends Amidst Raised Full-Year Guidance

Public Storage Declares Quarterly Dividends Amidst Raised Full-Year Guidance

Medicare Expands Diabetes Prevention Program to Reach More Patients

Medicare Expands Diabetes Prevention Program to Reach More Patients

Medicare has implemented significant changes to its Medicare Diabetes Prevention Program (MDPP), expanding access for more Medicare and Medicare Advantage beneficiaries, particularly those in rural and underserved areas. These changes, following advocacy from organizations like the AMA, aim to improve early identification and management of prediabetes to prevent the progression to type 2 diabetes. The MDPP offers 16 weekly sessions over six months, followed by six monthly follow-up sessions, providing training in diet, exercise, weight control strategies, and support from a specially trained coach. A key 2024 change covers nonfasting A1c tests for diabetes and prediabetes screening, making qualification easier. Additionally, there is no longer a limit on how many times a beneficiary can qualify, and the number of virtual MDPP providers has expanded, offering more flexible participation options.

General Mills Stock Performance Declines Over Decade, Dividend Yield Under Scrutiny

General Mills Stock Performance Declines Over Decade, Dividend Yield Under Scrutiny

General Mills Stock Performance Declines Over Decade, Dividend Yield Under Scrutiny